BioWorld

Sep. 5, 2007

View Archived Issues

J. Craig Venter Institute Publishes J. Craig Venter Genome Sequence

Read More

Clinical Data's Vilazodone Positive In Phase III Study

Read More

GNI Gains New Listing In Japan Raises $7.7M For Drug Discovery

Read More

Anacor Seeks $57.5M In IPO For Topical Boron-Based Pipeline

Read More

Other News To Note

Read More

Clinic Roundup

Read More

NeurogesX Reports Positive Phase III Study Of NGX-4010

NeurogesX Inc. reported the pain patch NGX-4010 met primary and secondary endpoints in a third Phase III trial, and the second in patients with postherpetic neuralgia. (BioWorld Today) Read More

Acambis Smallpox Vaccine Finally Wins U.S. Approval

Read More